Understand the source comparison
Side-by-Side Comparison
Class Hexapeptide GHRP Mechanism Hexapeptide ghrelin mimetic; GH release via GHSR, appetite increase, gastric motility Hexapeptide GHRP; potent GH via GHSR/CD36; cardioprotective independent of GH Evidence Grade B- Route Subcutaneous injection Typical Dose 100
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Class
- Hexapeptide GHRP
- Mechanism
- Hexapeptide ghrelin mimetic; GH release via GHSR, appetite increase, gastric motility
- Hexapeptide GHRP; potent GH via GHSR/CD36; cardioprotective independent of GH
- Evidence Grade
- B-
- Route
- Subcutaneous injection
- Typical Dose
- 100-300 mcg, 2-3x daily
- 100-200 mcg, 1-3x daily
- Half-Life
- ~2 hours
- FDA Status
- Not approved; research compound
- Reported Outcomes
- Robust GH release, appetite stimulation, gastroprotective effects
- Potent GH release (greater than GHRP-6), cardioprotective via CD36, cardiac function improvement (animal data)
- Reported Side Effects
- Intense hunger, cortisol/prolactin elevation, water retention
- Cortisol/prolactin increase, strong hunger, water retention
- Storage
- Refrigerate 2-8°C reconstituted; use within 21 days
- Cost (research grade)
- $30-60/month
- $40-80/month